CLINUVEL PHARMACEUTICALS LIMITED (CUVL) Shareholders’ equity 2024–2026
CLINUVEL PHARMACEUTICALS LIMITED (CUVL) shareholders’ equity at each fiscal year-end, per SEC filings.
$188.6MFY2026 · since FY2024: $135.0M → $188.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $188.6M | +20.3% |
| FY2025 | $156.7M | +16.1% |
| FY2024 | $135.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice